【2h】

Structure of tyrosine aminotransferase from Leishmania infantum

机译:婴儿利什曼原虫酪氨酸转氨酶的结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The trypanosomatid parasite Leishmania infantum is the causative agent of visceral leishmaniasis (VL), which is usually fatal unless treated. VL has an incidence of 0.5 million cases every year and is an important opportunistic co-infection in HIV/AIDS. Tyrosine aminotransferase (TAT) has an important role in the metabolism of trypanosomatids, catalyzing the first step in the degradation pathway of aromatic amino acids, which are ultimately converted into their corresponding l-2-oxoacids. Unlike the enzyme in Trypanosoma cruzi and mammals, L. infantum TAT (LiTAT) is not able to transaminate ketoglutarate. Here, the structure of LiTAT at 2.35 Å resolution is reported, and it is confirmed that the presence of two Leishmania-specific residues (Gln55 and Asn58) explains, at least in part, this specific reactivity. The difference in substrate specificity between leishmanial and mammalian TAT and the importance of this enzyme in parasite metabolism suggest that it may be a useful target in the development of new drugs against leishmaniasis.
机译:锥虫寄生虫婴儿利什曼原虫是内脏利什曼病(VL)的病原,除非治疗,否则通常是致命的。 VL每年发生50万例,是艾滋病毒/艾滋病的重要机会性共同感染。酪氨酸氨基转移酶(TAT)在锥虫的代谢中起重要作用,催化芳香族氨基酸降解途径中的第一步,最终将其转化为相应的1--2-含氧酸。与克鲁斯锥虫和哺乳动物中的酶不同,婴儿乳杆菌TAT(LiTAT)不能转氨基酮戊二酸。在此,报道了2.35Å分辨率的LiTAT的结构,并且证实存在两个利什曼原虫特异性残基(Gln55和Asn58)至少部分解释了这种特异性反应性。利什曼病和哺乳动物TAT之间底物特异性的差异以及该酶在寄生虫代谢中的重要性表明,它可能是开发抗利什曼病的新药的有用靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号